Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


March 30, 2015 5:54 AM ET

Healthcare Equipment and Supplies

Company Overview of Bausch & Lomb Incorporated

Company Overview

Bausch & Lomb Incorporated manufactures eye care products. The company offers contact and hydrophobic acrylic intraocular lenses; contact lens care, dry eye, allergy/redness relief, pharmaceutical, and surgical products; and eye vitamins and vision accessories. It also offers contract manufacturing services for sterile and non-sterile solutions, suspensions, ointments, gels, creams, nasals, and injectables. The company was formerly known as Bausch & Lomb Optical Company and changed its name to Bausch & Lomb Incorporated in March 1960. Bausch & Lomb Incorporated was founded in 1853 and is based in Rochester, New York. It has additional offices in Argentina, Australia, Austria, Belgium, Bulgar...

1400 North Goodman Street

Rochester, NY 14609

United States

Founded in 1853

13,000 Employees

Phone:

585-338-6000

Fax:

585-338-6896

Key Executives for Bausch & Lomb Incorporated

President of Asia-Pacific
Age: 69
Corporate Vice President and President of Latin America Operations
Executive Vice President of Global Business Operations & Process Excellence and Corporate Vice President
Chief Medical Officer and Executive Vice President
Age: 62
Head of Sales for US Vision Care Division
Compensation as of Fiscal Year 2014.

Bausch & Lomb Incorporated Key Developments

Bausch + Lomb Announces Availability of Enhanced BLIS Reusable Injector System for enVista Intraocular Lenses

Bausch + Lomb announced the availability of an enhanced BLIS Injector System, which is designed exclusively for use with the enVista, hydrophobic acrylic intraocular lens (IOL). With the new enhancements, eye care practitioners will be provided even greater control, allowing safe delivery of the enVista IOL through unenlarged phaco incisions as small as 2.2 mm. The BLIS injector system was first introduced in February 2014 and features a reusable hand piece made of high-quality, titanium material designed for both reliability and comfort. The proprietary disposable cartridge is designed for easy lens loading and wound entry and smooth delivery of enVista. The enhanced BLIS now includes a softened and tumble-polished plunger tip that is 2mm longer than the previous design, which helps facilitate easier placement in the capsular bag, in addition to several other features to ensure a seamless, positive customer experience.

Vision Source Selects Bausch + Lomb as Vendor for Eye Care Products

Bausch + Lomb announced that Vision Source has selected the company as a vendor in the therapeutics category and in contact lenses and lens care products. As part of the relationship, Vision Source will endorse Bausch + Lomb's products together with member pricing discounts and rebate programs. In the therapeutics category, members will be offered the line of Ocuvite and PreserVision eye vitamin and mineral supplements, Soothe eye drops for dry eyes, and Alaway eye drops. For skincare, the ELASTIderm eye product portfolio, which includes eye cream, eye gel and eye serum, will be available to members to help patient's revitalize the skin around their eyes with clinically proven ingredients.

Bausch + Lomb Introduces New Software and Advanced OCT Imaging System for VICTUS(R) Femtosecond Laser Platform

Valeant Pharmaceuticals International Inc. announced that its wholly owned subsidiary, Bausch + Lomb, has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for an advanced Swept Source OCT (Optical Coherence Tomography) imaging system and updated software for its VICTUS(R) Femtosecond Laser Platform that will provide surgeons with a new, redesigned interface. The intuitive interface is designed to allow faster, simpler customized treatment planning to help surgeons improve efficiency and patient-flow during surgical procedures. The Swept Source OCT imaging system boasts high resolution imaging of the entire procedure and can be used to drive incision depth and detail the architecture of arcuate incisions. Together, the new software and imaging system will deliver auto-recognition of key landmarks in the eye, including the pupil, anterior capsule and posterior capsule, along with the capsule tilt compensation to maximize lens fragmentation.

Similar Private Companies By Industry

Company Name Region
Julius Zorn, Inc. United States
Roscoe Medical, Inc. United States
Artegraft, Inc. United States
Boyd Industries, Inc. United States
Westone Laboratories, Inc. United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Bausch & Lomb Incorporated, please visit www.bausch.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.